Viewing StudyNCT06482788



Ignite Creation Date: 2024-07-17 @ 10:44 AM
Last Modification Date: 2024-10-26 @ 3:33 PM
Study NCT ID: NCT06482788
Status: RECRUITING
Last Update Posted: 2024-07-01
First Post: 2024-05-22

Brief Title: Perioperative Treatment of Resectable Adenocarcinoma of Esophagogastric Junction by Immunotherapy Adebrelimab Combined With Chemotherapy XELOX a Prospective Single-center Feasibility Study
Sponsor:
Organization: Ruijin Hospital